PROGENSA PCA3 Assay
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PROGENSA PCA3 Assay, covering 2012-11-07 to 2012-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result [NA]